2.64
price down icon1.49%   -0.04
after-market Handel nachbörslich: 2.67 0.03 +1.14%
loading

Autolus Therapeutics Plc Adr Aktie (AUTL) Neueste Nachrichten

pulisher
Jul 22, 2025

Autolus Therapeutics’ (AUTL) Buy Rating Reaffirmed at Needham & Company LLC - Defense World

Jul 22, 2025
pulisher
Jul 21, 2025

European Commission approves Autolus’ cell therapy for adult leukemia - Investing.com India

Jul 21, 2025
pulisher
Jul 21, 2025

Autolus Therapeutics’ CAR T Therapy AUCATZYL® (Obecabtagene Autoleucel) Granted European Marketing Authorization for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL) - GlobeNewswire Inc.

Jul 21, 2025
pulisher
Jul 09, 2025

Cambridge Investment Research Advisors Inc. Sells 2,160 Shares of Invesco KBW Property & Casualty Insurance ETF (NASDAQ:KBWP) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

1,867 Shares in Axsome Therapeutics, Inc. (NASDAQ:AXSM) Bought by DAVENPORT & Co LLC - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

DAVENPORT & Co LLC Trims Holdings in Janus Henderson Short Duration Income ETF (NYSEARCA:VNLA) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Vontobel Holding Ltd. Lowers Holdings in Autolus Therapeutics PLC Sponsored ADR (NASDAQ:AUTL) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Wealth Enhancement Advisory Services LLC Takes $258,000 Position in Taylor Morrison Home Corporation (NYSE:TMHC) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

TELUS International (Cda) (TSE:TIXT) Trading 2.1% Higher – What’s Next? - Defense World

Jul 09, 2025
pulisher
Jun 17, 2025

Closing Figures: Autolus Therapeutics plc ADR (AUTL)’s Negative Finish at 2.05, Down -3.30 - DWinneX

Jun 17, 2025
pulisher
Jun 12, 2025

NOV Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com

Jun 12, 2025
pulisher
Jun 05, 2025

Autolus shares surge 77% following InvestingPro’s April Fair Value signal By Investing.com - Investing.com India

Jun 05, 2025
pulisher
May 23, 2025

EMA committee endorses Autolus’ leukemia therapy obe-cel By Investing.com - Investing.com South Africa

May 23, 2025
pulisher
May 23, 2025

Autolus Therapeutics Gets Favorable Recommendation For Approval Of Cancer Therapy In EU: Retail Sentiment Brightens By Stocktwits - Investing.com India

May 23, 2025
pulisher
May 23, 2025

EMA committee endorses Autolus’ leukemia therapy obe-cel - Investing.com

May 23, 2025
pulisher
May 16, 2025

Autolus Therapeutics plc ADR (AUTL) Has A Gold Mine On Its Hands - Stocksregister

May 16, 2025
pulisher
May 08, 2025

Autolus reports $9M in Q1 product revenue, gains UK approval By Investing.com - Investing.com South Africa

May 08, 2025
pulisher
May 08, 2025

Autolus reports $9M in Q1 product revenue, gains UK approval - Investing.com

May 08, 2025
pulisher
Apr 30, 2025

AUTL’s Market Whiplash: -44.26% YTD Decline, -21.08% Plunge in 30 Days - investchronicle.com

Apr 30, 2025
pulisher
Apr 29, 2025

There is no doubt that Autolus Therapeutics plc ADR (AUTL) ticks all the boxes. - Sete News

Apr 29, 2025
pulisher
Apr 29, 2025

Autolus Therapeutics plc ADR (AUTL) receives a Buy rating from Goldman - knoxdaily.com

Apr 29, 2025
pulisher
Apr 28, 2025

AUTL’s valuation metrics: A comprehensive analysis - uspostnews.com

Apr 28, 2025
pulisher
Apr 28, 2025

Market Resilience: Autolus Therapeutics plc ADR (AUTL) Finishes Weak at 1.33, Down -5.00 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Market Update: Goosehead Insurance Inc (GSHD) Sees Positive Movement, Closing at 99.54 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

How Do Things Look For Autolus Therapeutics plc ADR (NASDAQ: AUTL) In The Short-Term? - Stocksregister

Apr 28, 2025
pulisher
Apr 25, 2025

UK approves Autolus leukemia therapy with conditions By Investing.com - Investing.com India

Apr 25, 2025
pulisher
Apr 25, 2025

For Autolus Therapeutics plc ADR [AUTL], Analyst sees a rise to $7.60. What next? - dbtnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

UK approves Autolus leukemia therapy with conditions - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

Autolus Therapeutics plc ADR [NASDAQ: AUTL] Sees Decrease in Stock Value - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

Market cap of i-80 Gold Corp [IAUX] reaches 279.54M – now what? - dbtnews.com

Apr 25, 2025
pulisher
Apr 25, 2025

Daiwa Securities lifts Bilibili Inc ADR [BILI] price estimate. Who else is bullish? - dbtnews.com

Apr 25, 2025
pulisher
Apr 23, 2025

Market Watch: Autolus Therapeutics plc ADR (AUTL)’s Noteworthy Gain, Closing at 1.60 - DWinneX

Apr 23, 2025
pulisher
Apr 23, 2025

It makes sense and dollars to buy Autolus Therapeutics plc ADR (AUTL) stock - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

How does PROG Holdings Inc (PRG) change from a tortoise to a hare? - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

Investors in cash trouble should check out BBB Foods Inc (TBBB) - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

Take off with Energous Corp (WATT): Get ready for trading - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

The growth track for Protalix BioTherapeutics Inc (PLX) has changed recently - Sete News

Apr 23, 2025
pulisher
Apr 23, 2025

Tokio Marine Holdings, Inc. Sponsored ADR (OTCMKTS:TKOMY) Short Interest Update - Defense World

Apr 23, 2025
pulisher
Apr 07, 2025

PSQ Holdings Inc (PSQH) may enjoy gains as insiders got busy in the recent days - knoxdaily.com

Apr 07, 2025
pulisher
Mar 31, 2025

Truist cuts Autolus stock price target to $10, maintains buy rating By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Truist cuts Autolus stock price target to $10, maintains buy rating - Investing.com India

Mar 31, 2025
pulisher
Mar 24, 2025

Agilent tech aids in FDA approval of Autolus CAR T therapy By Investing.com - Investing.com South Africa

Mar 24, 2025
pulisher
Mar 24, 2025

Arhaus Inc (NASDAQ: ARHS)’s Stock Adds 0.70%, Making It A Good Investment - Stocks Register

Mar 24, 2025
pulisher
Mar 24, 2025

Agilent tech aids in FDA approval of Autolus CAR T therapy - Investing.com UK

Mar 24, 2025
pulisher
Mar 20, 2025

Truist maintains $11 target on Autolus stock amid strong demand By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Mizuho maintains $12 target on Autolus stock after Q4 update - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Autolus reports progress in commercial launch and financials By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Truist maintains $11 target on Autolus stock amid strong demand - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Autolus reports progress in commercial launch and financials - Investing.com India

Mar 20, 2025
pulisher
Mar 20, 2025

Earnings call transcript: Autolus Therapeutics Q4 2024 earnings and market reaction By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 12, 2025

Autolus at Leerink’s Global Healthcare Conference: Strategic Moves in CAR T Therapy - Investing.com

Mar 12, 2025
pulisher
Mar 03, 2025

10 Best UK Growth Stocks to Buy Now - Insider Monkey

Mar 03, 2025
pulisher
Feb 27, 2025

Stock Surge: Autolus Therapeutics plc ADR (AUTL) Closes at 1.82, Marking a 1.68 Increase/Decrease - The Dwinnex

Feb 27, 2025
pulisher
Feb 12, 2025

It would be worthwhile to take a closer look at Autolus Therapeutics plc ADR (AUTL) - US Post News

Feb 12, 2025
pulisher
Feb 10, 2025

Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News

Feb 10, 2025
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):